about
Association between HMGB1 and COPD: A Systematic ReviewOxidative stress in benign prostatic hyperplasia: a systematic reviewChemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives?Unmet diagnostic needs in contact oral mucosal allergiesNeurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?Different clinical allergological features of Taenia solium infestationSystematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's diseaseEffect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura.Cutaneous adverse reactions to lenalidomide.The soft computing-based approach to investigate allergic diseases: a systematic review.Association between HMGB1 and asthma: a literature review.Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives.Anticancer Potential of Citrus Juices and Their Extracts: A Systematic Review of Both Preclinical and Clinical Studies.25-Hydroxyvitamin D, IL-31, and IL-33 in children with allergic disease of the airwaysBergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells.Cytokine network involvement in subjects exposed to benzene.Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a.Passiflora incarnata L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials.Modification of interleukin-15 serum levels in workers exposed to chemotherapeutic agentsAge-related modifications in circulating IL-15 levels in humans.Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depressionLipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphomaSerum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.Protein carbonyl group content in patients affected by familiar chronic nail candidiasisEffect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease.Interleukin-18 and CD30 serum levels in patients with moderate-severe depressionCatching allergy by a simple questionnaireIncreased levels of interleukin 31 (IL-31) in osteoporosis.Different co-sensitizations could determine different risk assessment in peach allergy? Evaluation of an anaphylactic biomarker in Pru p 3 positive patients.Smoking, health and ageingMastocytosis and systemic sclerosis: a clinical associationAllergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.Urticaria and thyroid autoimmunity.Urticaria and bacterial infections.Chlamydophila psittaci seropositivity and serum levels of soluble intercellular adhesion molecule-1 in farmers.Allergic contact dermatitis: immune system involvement and distinctive clinical cases.Airborne contact dermatitis to drugs.Chronic idiopathic urticaria and Graves' disease.Oxidative stress in oncohematologic diseases: an update.Rosmarinus officinalis L. as cause of contact dermatitis.
P50
Q26770022-A1F39030-F34D-40B5-82F1-92CAFA4A06BAQ26859241-808D047B-C4DF-48DC-AF1D-0ADF400634FAQ28066511-A9427DE7-7F7C-4B04-B749-8AB7FC8A182DQ28069917-2DCA02F8-ADCB-42A8-B5BB-DDD939670078Q28076243-EDB33EDC-2D99-4305-BBA7-1146683CD2FAQ28078335-B5EDCF74-DEA8-4BE8-8115-75F77DBD8E31Q28315752-F828CFD5-6BD3-42BF-B091-C78B08FD3581Q33415190-45DA7C3F-81B2-4F0C-9CE2-C663C6513508Q33416305-85A75AED-8442-4003-86D4-2326E74676E0Q33560390-D8EF8F62-218C-4139-8DB1-1F6A65982AF9Q33801198-9344F66B-C47E-46AC-8BC8-FFABD2B0B5DDQ33814452-F74EF834-F655-41B5-8825-B96762E75FBFQ33854738-4ED5BFF0-7CF1-466F-990C-E0E5CA1E03B4Q33904814-1AB6DC4F-B941-4727-BA53-2EADDBF1FF29Q34041849-F400F84A-3147-487B-B2B0-26EC6DCBAFB8Q34118812-8E09A72F-17AD-48FE-8337-0C2D041C17C2Q34167958-09ED72C7-5A0D-4B3E-AC22-199AF9829807Q34378835-83B99AF7-6FF8-4C4D-9C07-8832AD7CA705Q34803304-976FCF32-7266-4129-AEA6-08639FD4ACF0Q34894566-A576C8C0-D6D6-4DC4-98C4-52E2F0D5693DQ35609152-6222D110-9075-403D-B8DB-2B0A012FD70FQ35609226-30F2E1A6-B083-4A24-BCB8-8A6B3477B880Q35609284-341A0F71-511E-44AD-BA4B-770F68B84F09Q35609331-645CC7FC-3319-40E8-AECB-21469ABC9385Q35609345-197FBDD3-E29D-4C70-A5D1-C989C68946B6Q35609495-068A5FF8-6B73-4A07-A680-8D8A7B775E4EQ35730145-37EA43AA-FD05-48BF-B5D7-B322EB428AA1Q36142219-DE41A095-4894-40CC-9582-9A747CFFB7A2Q36340985-65AA3F4A-1752-420D-A03A-A43747A2CCF4Q36930981-F240A1F6-66C0-475D-8D66-63413D1BE578Q37331016-BFA2ACDC-34C6-453E-A5D4-0367DC53C56AQ37623049-20C31D16-0206-4334-801A-050C7B56C219Q37842509-C1A5677B-1261-47AF-96A2-1C6B215D6A42Q37844317-B43C5202-7BA5-469F-972C-A2B5A0084BD4Q37856039-3398579D-EACE-4484-8520-F3E6218CEF09Q37901674-3761EE27-90D6-46C6-93D1-F6F6F6E7413AQ37996676-CF82CD7D-8B95-41D4-AB1D-D728AD215CD7Q38101011-AE0D363E-22FF-46F2-AFC3-F83210B52FD8Q38115588-684E6818-6E02-40C2-AB8E-CE095E16281CQ38119334-804B230F-5D0B-46BF-AB1D-758A451A73FC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Sebastiano Gangemi
@ast
Sebastiano Gangemi
@en
Sebastiano Gangemi
@es
Sebastiano Gangemi
@nl
Sebastiano Gangemi
@sl
type
label
Sebastiano Gangemi
@ast
Sebastiano Gangemi
@en
Sebastiano Gangemi
@es
Sebastiano Gangemi
@nl
Sebastiano Gangemi
@sl
prefLabel
Sebastiano Gangemi
@ast
Sebastiano Gangemi
@en
Sebastiano Gangemi
@es
Sebastiano Gangemi
@nl
Sebastiano Gangemi
@sl
P106
P1153
7004548044
P21
P214
2144147665862060670005
P31
P496
0000-0001-7001-6532
P734
P735
P7859
viaf-2144147665862060670005